Consistent with FDA labeling, GLP-1 RAs amplify hypoglycemia risk when combined with insulin or sulfonylureas 42 , a complication linked to seizures, syncope, and tremors 43
My Position: Yes, With Preparation I think psychiatrists who work with patients dealing with both metabolic and mental health concerns should absolutely consider prescribing GLP-1 medications as part of integrated care
This protective effect has been substantiated through subgroup analyses stratified by histological type, race, gender, and smoking status [19]
The TBARS concentration was calculated using standard curves of increasing 1,1,3,3-tetramethoxypropane concentrations and expressed as nmol/g tissue
Oral glucose tolerance evaluation across the combined study population indicated no adverse support for carbohydrate metabolism